Apieron, Inc. Files Infringement Complaint Against Aerocrine AB, Aerocrine AG and Mr. Magnus Pelles
16/07/2009 16:37
PR Newswire
MENLO PARK, California, July 16 /PRNewswire/ --
Today, Apieron, Inc. (http://www.apieron.com/) reported that it filed a
patent infringement complaint against Aerocrine AB, Solna, Sweden, Aerocrine
AG, Bad Homburg, Germany and Mr. Magnus Pelles, Usingen, Germany in the
Regional Court of Mannheim, Germany. Apieron, makers of the Insight(TM) eNO
System for measurement of exhaled nitric oxide, presented this complaint
against Aerocrine on the grounds that they are offering and putting on the
market portable and stationary analyzers to detect the nitric oxide content
in breath, which Apieron considers to be infringing the German part of its
European Patent EP 0 892 926.
About Apieron, Inc.
Apieron, Inc. is a private venture-backed medical device company
dedicated to developing innovative solutions to improve the standard of care
for people with asthma. Its Insight(TM) eNO System measures exhaled nitric
oxide (eNO) which is a well established indicator of airway inflammation for
asthma management. Utilizing a proprietary biosensor, Apieron's Insight eNO
System can detect trace amounts of nitric oxide in a patient's breath. It is
highly accurate, non-invasive, safe, easy to use, and provides results in
less than a minute.
Contact:
Steve DiMattia
+1-646-201-5445
Steve DiMattia, +1-646-201-5445, for Apieron, Inc.
-